People · Operator
Named in public records as an officer, director or promoter · active 2010–2020 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Phoenix Biotechnology Inc | — | Pharmaceuticals | Series A | $10.9M | $148.1M | 2010 |
Crandell Addington at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Crandell Addington on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeffrey S. Thompson | 1 | 2 |
| John W. Creamer | 1 | 1 |
| Lou Kost, Jr. | 1 | 1 |
| Macdonald T. Haskell | 1 | 1 |
| Andrew J. Butler | 1 | 1 |
| Carlos Torres | 1 | 1 |
| Lou T. Kost | 1 | 1 |
| Robert T. Newman | 1 | 1 |
| Andrew J. Whitney | 1 | 1 |
| Robert A. Newman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.